Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. [electronic resource]
Producer: 20031106Description: 2191-202 p. digitalISSN:- 0006-8950
- Animals
- Aspartic Acid -- analogs & derivatives
- Axons -- chemistry
- Benzoxazines
- Cannabinoids -- therapeutic use
- Cyclohexanols -- therapeutic use
- Dizocilpine Maleate -- therapeutic use
- Encephalomyelitis, Autoimmune, Experimental
- Excitatory Amino Acid Agonists -- therapeutic use
- Gene Deletion
- Humans
- Mice
- Mice, Transgenic
- Monomeric GTP-Binding Proteins -- genetics
- Morpholines -- therapeutic use
- Multiple Sclerosis -- drug therapy
- N-Methylaspartate -- therapeutic use
- Naphthalenes -- therapeutic use
- Nerve Degeneration
- Nuclear Proteins -- genetics
- Receptors, Cannabinoid
- Receptors, Drug -- agonists
- Receptors, N-Methyl-D-Aspartate -- antagonists & inhibitors
- Retina -- drug effects
- Saccharomyces cerevisiae Proteins
- Spinal Cord -- pathology
- Uveitis -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.